Marqeta, Inc.
MQ Nasdaq Services-Prepackaged Software Financials FY2019βFY2025
What Marqeta, Inc. does
No business description yet.
- Legal name
- Marqeta, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001522540-26-000017
0001522540
Revenue and margins
Marqeta, Inc. had $625M of revenue in fiscal 2025, up 23.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $161M in fiscal 2025, 25.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Marqeta, Inc. returned $391M to shareholders in fiscal 2025, 243% of free cash flow. The diluted share count fell 10.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Marqeta, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.7B | $1.6B | $1.2B | $1.1B | $772M |
| Current ratio | 7.6x | 6.2x | 4.1x | 3.4x | 1.6x |
| Quick ratio | 7.6x | 6.2x | 4.1x | 3.4x | 1.6x |
| Total assets | $1.8B | $1.8B | $1.6B | $1.5B | $1.5B |
| Total liabilities | $257M | $297M | $346M | $378M | $763M |
| Shareholders' equity | $1.6B | $1.5B | $1.2B | $1.1B | $762M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 8 | 2 / 8 | 5 / 8 | 6 / 8 | 5 / 8 |
| Accruals ratio | β | β21.4% | β19.3% | β9.5% | β14.5% | β2.0% | β11.8% |
| Altman Z'' | β | 0.33 | 10.69 | 8.72 | 5.22 | 5.06 | 1.20 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $143M | $290M | $517M | $748M | $676M | $507M | $625M |
| Gross profit | $60.5M | $118M | $232M | $320M | $330M | $352M | $437M |
| Operating income | β$58.9M | β$47.1M | β$162M | β$210M | β$283M | β$24.5M | β$46.4M |
| Pretax income | β$58.2M | β$47.6M | β$165M | β$185M | β$231M | $28.1M | β$13.3M |
| Income tax | $0.0M | $0.1M | β$0.6M | β$0.1M | β$7.6M | $0.8M | $0.6M |
| Net income | β$58.2M | β$47.7M | β$164M | β$185M | β$223M | $27.3M | β$13.9M |
| Net income to common | β$122M | β$47.7M | β$164M | β$185M | β$223M | $27.3M | β$13.9M |
| Diluted shares | 0.11B | 0.12B | 0.36B | 0.55B | 0.53B | 0.52B | 0.46B |
| Cash flow | |||||||
| Cash from operations | β$15.4M | $50.3M | $57.0M | β$13.0M | $21.1M | $58.2M | $163M |
| Capital expenditure | $4.9M | $2.4M | $2.7M | $2.3M | $0.8M | $2.4M | $1.8M |
| Free cash flow | β$20.3M | $47.9M | $54.2M | β$15.3M | $20.3M | $55.8M | $161M |
| Depreciation and amortization | $3.1M | $3.5M | $3.5M | $3.9M | $10.7M | $17.5M | $27.2M |
| Stock-based compensation | $21.8M | $28.2M | $143M | $108M | $128M | $137M | $105M |
| Acquisitions | β | β | $0.0M | $0.0M | $136M | $0.0M | $45.7M |
| Share buybacks | β | $0.0M | $0.0M | $78.1M | $190M | $154M | $391M |
| Dividends and buybacks | β | $0.0M | $0.0M | $78.1M | $190M | $154M | $391M |
| Balance sheet | |||||||
| Cash and short-term investments | $60.3M | $370M | $1.7B | $1.6B | $1.2B | $1.1B | $772M |
| Current assets | β | $431M | $1.8B | $1.7B | $1.4B | $1.2B | $1.2B |
| Current liabilities | β | $141M | $238M | $283M | $337M | $371M | $749M |
| Property and equipment, net | β | $9.5M | $9.7M | $7.4M | $18.8M | $37.5M | $59.9M |
| Goodwill | β | β | β | $0.0M | $124M | $124M | $155M |
| Intangible assets | β | β | β | $0.0M | $35.6M | $29.8M | $51.4M |
| Total assets | β | $458M | $1.8B | $1.8B | $1.6B | $1.5B | $1.5B |
| Total liabilities | β | $170M | $257M | $297M | $346M | $378M | $763M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$198M | β$214M | $1.6B | $1.5B | $1.2B | $1.1B | $762M |
| Margins | |||||||
| Gross margin | 42.2% | 40.6% | 44.8% | 42.8% | 48.7% | 69.4% | 70.0% |
| Operating margin | β41.1% | β16.2% | β31.3% | β28.0% | β41.9% | β4.8% | β7.4% |
| EBITDA margin | β38.9% | β15.0% | β30.6% | β27.5% | β40.3% | β1.4% | β3.1% |
| Net margin | β40.6% | β16.4% | β31.7% | β24.7% | β33.0% | 5.4% | β2.2% |
| FCF margin | β14.2% | 16.5% | 10.5% | β2.0% | 3.0% | 11.0% | 25.7% |
| Returns | |||||||
| Return on capital employed | β | β14.9% | β10.2% | β14.1% | β22.6% | β2.2% | β6.0% |
| Return on equity | β | β | β24.1% | β12.1% | β16.4% | 2.3% | β1.5% |
| Return on assets | β | β10.4% | β14.3% | β10.3% | β13.3% | 1.8% | β0.9% |
| Return on tangible equity | β | β | β10.4% | β12.5% | β20.6% | 2.9% | β2.5% |
| Growth | |||||||
| Revenue growth | β | 102.6% | 78.2% | 44.7% | β9.6% | β25.0% | 23.3% |
| Net income growth | β | β | β | β | β | β | β151.0% |
| FCF growth | β | β | 13.2% | β128.2% | β | 174.1% | 188.4% |
| Share count change | β | 8.0% | 195.1% | 50.3% | β2.4% | β2.6% | β10.9% |
| Financial health | |||||||
| Current ratio | β | 3.1x | 7.6x | 6.2x | 4.1x | 3.4x | 1.6x |
| Quick ratio | β | 3.1x | 7.6x | 6.2x | 4.1x | 3.4x | 1.6x |
| Capital allocation | |||||||
| Capex / revenue | 3.4% | 0.8% | 0.5% | 0.3% | 0.1% | 0.5% | 0.3% |
| Stock comp / revenue | 15.2% | 9.7% | 27.6% | 14.4% | 18.9% | 26.9% | 16.8% |
| Payouts / FCF | β | 0.0% | 0.0% | β | 936.1% | 277.0% | 243.4% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 5.0 | 2.0 | 5.0 | 6.0 | 5.0 |
| Altman Z'' | β | 0.3 | 10.7 | 8.7 | 5.2 | 5.1 | 1.2 |
| Accruals ratio | β | β21.4% | β19.3% | β9.5% | β14.5% | β2.0% | β11.8% |
Source: SEC EDGAR XBRL filings (CIK 0001522540). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.